23 results
10-K
2020 FY
ONCR
Oncorus, Inc.
10 Mar 21
Annual report
4:12pm
significantly harm our reputation and business prospects.
Serious adverse events, undesirable side effects or other unexpected properties of our current … ;
we could be sued and held liable for harm caused to patients; and
our reputation may suffer.
If any of our product candidates are associated
424B4
ONCR
Oncorus, Inc.
12 Feb 21
Prospectus supplement with pricing info
4:23pm
interim or preliminary or topline data and final data could significantly harm our reputation and business prospects.
Serious adverse events, undesirable … outlining the risks of such side effects for distribution to patients;
we could be sued and held liable for harm caused to patients; and
our reputation may
DRS
f8fhqyhn046m qn
28 Jan 21
Draft registration statement
12:00am
DRS
EX-10.21
ryccriw
28 Jan 21
Draft registration statement
12:00am
10-Q
rzqrnfwntj hfj
12 Nov 20
Quarterly report
8:01am
424B4
k7xy8uyu94g4 714x
2 Oct 20
Prospectus supplement with pricing info
12:00am
S-1
EX-10.19
32a73kf77 btojchfe
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.10
nnlz6 f0t8z
11 Sep 20
IPO registration
4:49pm
S-1
EX-10.16
7bl0hfzfqlbflhwu
11 Sep 20
IPO registration
4:49pm
S-1
kukkt5ncwmkhnyp4a7
11 Sep 20
IPO registration
4:49pm
DRS/A
82xeqdyvojpmr
26 Aug 20
Draft registration statement (amended)
12:00am
DRS/A
9hg 3z0yf76d
29 Jul 20
Draft registration statement (amended)
12:00am
DRS/A
duykc
20 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
EX-10.19
zv53gnda5g
20 Dec 19
Draft registration statement (amended)
12:00am
DRS
EX-10.16
pt2z2tf896bj
31 Oct 19
Draft registration statement
12:00am